1-10 of 10
extracorporeal circulation
Close
Sort by
Journal Articles

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Nabil K. Thalji, MD PhD, Prakash A Patel, MD, Rodney M. Camire, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3640.
https://doi.org/10.1182/blood-2019-125955
Published: 2019
Journal Articles

Protective Effects of Carbon Monoxide Delivered By Corm-401 in Hyperhemolysis in Patients with Sickle Cell Disease

Nguyen-Peyre Kim-Anh, PhD, Bodivit Gwellaouen, Foresti Roberta, PhD, Kiger Laurent, PhD, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Alicia Jouard, Sadaf Pakdaman, Seguin Marion, Marden Micheal, PhD, France Pirenne, MD PhD, Motterlini Roberto, PhD, Pablo Bartolucci, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2367.
https://doi.org/10.1182/blood-2018-99-112900
Published: 2018
Journal Articles

Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent

Petra Jilma-Stohlawetz, MD, Schima Heinrich, PhD, Martin Stoiber, Peter Quehenberger, MD, Sabine Schranz, RN, Bernd Jilma, MD
Journal: Blood
Blood (2013) 122 (21): 3602.
https://doi.org/10.1182/blood.V122.21.3602.3602
Published: 2013
Journal Articles

A Novel Test for the Rapid Rule Out of Heparin-Induced Thrombocytopenia Diagnosis in Intensive Care unit patients

Vassiliki Galea, Francoise Robert, Patrick Van Dreden, Barry J Woodhams, Grigoris T Gerotziafas, Mohamed Hatmi, Ismail Elalamy
Journal: Blood
Blood (2012) 120 (21): 1119.
https://doi.org/10.1182/blood.V120.21.1119.1119
Published: 2012
Journal Articles

Excess Factor XIII (FXIII) Consumption During Cardiopulmonary Bypass Surgery in a Patient with Congenital FXIII Deficiency

Maissaa Janbain, MD, Cindy A. Leissinger, MD
Journal: Blood
Blood (2012) 120 (21): 4632.
https://doi.org/10.1182/blood.V120.21.4632.4632
Published: 2012
Journal Articles

Efficacy of Fondaparinux in the Treatment of Heparin-Induced Thrombocytopenia with Venous Thromboembolism: Reduction of Thromboembolic Burden, Normalization of Platelet Count and Disappearance of Anti-Platelet Factor 4/Heparin Antibodies.

Franco Piovella, MD, Marisa Barone, MD, Chiara Beltrametti, MD, Chiara Piovella, MD, Andrea M. D’Armini, MD, Federico Capra Marzani, MD, Vittorio Arici, MD, Mara De Amici, MD, Stefano L. Barco, MS, Gianluca Castellani, MD, Martin Langer, MD
Journal: Blood
Blood (2006) 108 (11): 575.
https://doi.org/10.1182/blood.V108.11.575.575
Published: 2006
Journal Articles

Argatroban for Anticoagulation during Cardiopulmonary Bypass.

Monte E. Martin, MD, Goetz H. Kloecker, MD, MSP.H., Anand Patel, MD, Damian A. Laber, MD, F.A.C.P.
Journal: Blood
Blood (2005) 106 (11): 4150.
https://doi.org/10.1182/blood.V106.11.4150.4150
Published: 2005
Journal Articles

The Determination of the Inhibitory Activity of Some Factor VIII Type II Inhibitor Antibodies Is Biased by the Type of Factor VIII Assay.

Marc G. Jacquemin, MD, Seb Lamprecht, MSc, Renaud Lavend’homme, MSc, Jan Roodt, MSc, Bernard Chatelain, MD, Veronique Deneys, MD, Jeroen Dewaele, MSc, Jean-Marie Stassen, PhD, Muriel Meiring, PhD, Jean Marie Saint-Remy, MD, Henry Pieters, PhD, Philip Badenhorst, MD
Journal: Blood
Blood (2005) 106 (11): 3200.
https://doi.org/10.1182/blood.V106.11.3200.3200
Published: 2005
Journal Articles

Antithrombotic Effects of Concomitant Administration of BAY 59–7939 with Enoxaparin or Heparin - Interaction Study.

Elisabeth Perzborn, PhD, Brigitte Arndt
Journal: Blood
Blood (2004) 104 (11): 1863.
https://doi.org/10.1182/blood.V104.11.1863.1863
Published: 2004
Journal Articles

Compstatin Inhibits Complement and Cellular Activation in Whole Blood in Two Models of Extracorporeal Circulation

Bo Nilsson, Rolf Larsson, Jaan Hong, Graciela Elgue, Kristina Nilsson Ekdahl, Arvind Sahu, John D. Lambris
Journal: Blood
Blood (1998) 92 (5): 1661–1667.
https://doi.org/10.1182/blood.V92.5.1661
Published: 1998